Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-05-09

FDA Tentative Approval: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Solco Healthcare US, LLC)

View source ↗

Summary

FDA issued tentative approval for a generic fixed-dose combination of irbesartan and hydrochlorothiazide (Solco Healthcare US, LLC) under Original Application A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRBESARTAN AND HYDROCHLOROTHIAZIDE (irbesartan and hydrochlorothiazide)

Snippet

ORIG TA for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)